Back

Use of sacubitril/valsartan beyond guidelines

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Clinical Cases - Chronic Heart Failure – Pathophysiology and Mechanisms Heart Failure with Reduced Ejection Fraction (HFrEF) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Hakan Altay

Baskent University Istanbul Hospital, Istanbul (Turkiye)

6 More presentations in this session

Presentation thumbnail
Anagrelide induced cardiomyopathy: a case report
Doctor A. Tsipis (Athens, GR)
Abstract
Presentation thumbnail
Questions and doubts about ARNI therapy in a patient with heart failure: a real life experience
Mr D. Kosuta (Ljubljana, SI)
Abstract
Presentation thumbnail
Dilated cardiomyopathy with severe left ventricular dysfunction and right atrial thrombi secondary to thyrotoxicosis.
Doctor S. Antit (Tunis, TN)
Abstract Slides
Presentation thumbnail
Case 5-Fluorouacil-Induced Myocardial Infarction and Recurrent Stent Thrombosis; An Unusual Case
Doctor B. Lefebvre (Montreal, CA)
Abstract Slides
Presentation thumbnail
The legend of a stone heart
Doctor M. Rusu (Buzau, RO)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Clinical Cases - Chronic Heart Failure – Pathophysiology and Mechanisms

The Event

Event poster

Heart Failure 2018

26 May - 29 May 2018
You may be interested in
thumbnail
Congress Presentation
Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Session
Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources